Link: https://links.sgx.com/1.0.0/corporate-announcements/GW0PNXUT3BW3STQU/8f6a3ac3e348b1a1024a4a55206ed258a77698c0b8d8165d5969ed668d4da080

Summary:

• Group revenue decreased by 3.5% to S$25.97 million for FY2025, mainly due to lower contributions from Allied Health Services and general practitioner clinics, despite increased specialist clinic revenue.

• Net loss after tax was S$3.74 million, compared to a profit of S$2.38 million in FY2024; loss attributable to owners was S$4.03 million.

• Key negatives: impairment of goodwill (S$2.66 million), higher employee expenses from new clinics, and increased consultancy/marketing costs due to rebranding and overseas expansion.

• Non-current assets declined, mainly due to depreciation, plant and equipment impairments, and goodwill write-offs.

• Cash and cash equivalents stood at S$5.2 million as of 30 June 2025, down from S$6.86 million a year prior.

• No dividend was declared for FY2025, given financial performance and capital commitments.

• The Group continues digital transformation of clinics and seeks regional partnerships to expand its Paincare ecosystem.